{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"description":"All time to event endpoints will be evaluated using Kaplan Meier estimates and survival curves will be generated based on these estimates.","groups":[{"description":"Patients receive FR901228 (depsipeptide) IV at 13 mg/m2 over 4 hours on days 1, 8, and 15. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity.\n\nromidepsin: Given IV","id":"OG000","title":"Treatment (Romidepsin)"}],"populationDescription":"Data not collected. As the first stage goal of 8 patients with disease control was not achievable, further follow up was not done.","reportingStatus":"POSTED","timeFrame":"Up to 2 years","title":"Time to Progression","type":"SECONDARY"}